Angiodynamics Inc Quick Ratio (ANGO) starting from the fourth quarter 2026 to fourth quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Angiodynamics Inc   (NASDAQ: ANGO)

Angiodynamics Inc 's Quick Ratio

ANGO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Angiodynamics Inc 's Cash & cash equivalent grew by 42.46 % in the Q4 2026 sequentially, faster than Current Liabilities, this led to improvement in Angiodynamics Inc 's Quick Ratio to 0.72, Quick Ratio remained below Angiodynamics Inc average.

Within Medical Equipment & Supplies industry 126 other companies have achieved higher Quick Ratio than Angiodynamics Inc in fourth quarter 2026. While Quick Ratio total ranking in the fourth quarter 2026 has deteriorated compared to the prior quarter from 15 to 2076.

Explain Quick Ratio?
How much Cash & cash equivalents ANGO´s has?
What are ANGO´s Current Liabilities?




ANGO Quick Ratio (May 31 2026)
Q4
(Feb 28 2026)
Q3
(Nov 30 2025)
Q2
(Aug 31 2025)
Q1
(May 31 2025)
Q4
Y / Y Current Liabilities Change -1.94 % -15.27 % -16.41 % -10.97 % -16.41 %
Y / Y Cash & cash equivalent Change -3.63 % -15.53 % -26.51 % -29.53 % -26.51 %
Quick Ratio MRQ 0.72 0.57 0.73 0.57 0.73
ANGO's Total Ranking # 2076 # 15 # 13 # 28 # 370
Seq. Current Liabilities Change 13.09 % -13.3 % 11.59 % -10.39 % -2.28 %
Seq. Cash & cash equivalent Change 42.46 % -32.35 % 44.2 % -30.65 % 24.87 %



Quick Ratio fourth quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 127
Healthcare Sector # 681
Overall Market # 2076


Quick Ratio Statistics
High Average Low
5.67 1.05 0.18
(Aug 31 2011)   (Feb 28 2014)




Financial Statements
Angiodynamics Inc 's Current Liabilities $ 75 Millions Visit ANGO's Balance sheet
Angiodynamics Inc 's Cash & cash equivalent $ 54 Millions Visit ANGO's Balance sheet
Source of ANGO's Sales Visit ANGO's Sales by Geography


Cumulative Angiodynamics Inc 's Quick Ratio

ANGO's Quick Ratio for the trailling 12 Months

ANGO Quick Ratio

(May 31 2026)
12 Months
(Feb 28 2026)
12 Months
(Nov 30 2025)
12 Months
(Aug 31 2025)
12 Months
(May 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth -11.42 % -14.91 % -13.41 % -7.09 % 1.17 %
Y / Y Cash & cash equivalent TTM Growth -19.59 % -25.22 % -31.61 % -15.21 % -9.74 %
Quick Ratio TTM 0.65 0.66 0.65 0.69 0.72
Total Ranking TTM # 4030 # 35 # 2526 # 66 # 194
Seq. Current Liabilities TTM Growth -0.52 % -3.99 % -4.77 % -2.61 % -4.44 %
Seq. Cash & cash equivalent TTM Growth -1.08 % -3.56 % -9.36 % -7.01 % -8.01 %


On the trailing twelve months basis In spite of the year on year decrease in ANGO's Current Liabilities to $74.72 millions, cumulative Quick Ratio to 0.65 below the ANGO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 203 other companies have achieved higher Quick Ratio than Angiodynamics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2026 from 35 to 4030.

Explain Quick Ratio?
How much Cash & cash equivalents ANGO´s has?
What are ANGO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 204
Healthcare Sector # 898
Within the Market # 4030


trailing twelve months Quick Ratio Statistics
High Average Low
1.78 0.71 0.23
(Aug 31 2019)   (Aug 31 2014)




Companies with similar Quick Ratio in the quarter ending May 31 2026, within Medical Equipment & Supplies Industry Quick RatioMay 31 2026 MRQ Cash & cash equivalentMay 31 2026 MRQ Current Liabilities
Tactile Systems Technology Inc   1.83 $ 69.853  Millions$ 38.253  Millions
Tandem Diabetes Care Inc   1.80 $ 455.996  Millions$ 253.005  Millions
Inspire Medical Systems inc   1.79 $ 127.761  Millions$ 71.282  Millions
Warby Parker Inc   1.79 $ 292.674  Millions$ 163.480  Millions
Capsovision Inc   1.76 $ 9.077  Millions$ 5.158  Millions
Anika Therapeutics Inc   1.73 $ 38.412  Millions$ 22.147  Millions
Genedx Holdings Corp   1.71 $ 132.548  Millions$ 77.648  Millions
Beta Bionics Inc   1.70 $ 44.318  Millions$ 26.017  Millions
Merit Medical Systems Inc  1.70 $ 450.906  Millions$ 264.933  Millions
Seastar Medical Holding Corp  1.60 $ 6.959  Millions$ 4.353  Millions
Tela Bio Inc   1.59 $ 30.424  Millions$ 19.080  Millions
Conexeu Sciences Inc   1.55 $ 1.971  Millions$ 1.272  Millions
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions
Sintx Technologies Inc   1.21 $ 3.590  Millions$ 2.977  Millions
Vaso Corporation  1.17 $ 38.291  Millions$ 32.863  Millions
Koru Medical Systems Inc   1.15 $ 8.288  Millions$ 7.180  Millions
Establishment Labs Holdings Inc   1.10 $ 71.157  Millions$ 64.558  Millions
Treace Medical Concepts Inc   1.10 $ 45.619  Millions$ 41.496  Millions
Resmed Inc   1.05 $ 1,469.234  Millions$ 1,395.110  Millions
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions

Date modified: 2026-09-08T15:22:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.